Byondis
Manufacturing · Netherlands · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Microweg 4, Nijmegen, Gelderland, 6503 G...Phone Number
+31 246795100Website
www.byondis.comRevenue
$49.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Byondis
Byondis is a biotechnology company focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. They leverage their proprietary platforms and integrated R&D and manufacturing capabilities to create novel therapies that enhance selectivity and therapeutic index. Their product pipeline includes promising candidates targeting various oncological indications, such as BYON4228 and BYON4413. Byondis aims to deliver breakthrough solutions in oncology through their advanced technologies and commitment to research.Explore more
Byondis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Byondis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Byondis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Byondis launches new products
Byondis, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Byondis has new funding data
Check if Byondis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Byondis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Byondis
Click to see if Byondis had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Byondis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Byondis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Byondis.
Byondis Tech Stack
A closer look at the technologies used by Byondis
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Byondis News & Media
ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
NIJMEGEN, The Netherlands--(BUSINESS WIRE)-- Byondis B.V., an independent biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces today the appointment of Christoph Korpus, PhD, MBA, as Chief ExecutiveByondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as Chief Business Officer (CBO). Mr. Korpus brings more than 15 years of pharmaceutical experience to Byondis. “Christoph will play a pivotal role in advancing our pipeline of novel antibody conjugates and monoclonal antibody-based therapeutics through clinical dByondis Appoints Louis Denis, M.D., as Chief Medical Officer
NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Louis Denis, M.D. as Chief Medical Officer. Dr. Denis brings more than 30 years of clinical development leadership and oncology expertise to Byondis. “We are excited that Louis has joined the Byondis team. Building on our successful proprietary drug discovery, research and development and i
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Byondis
Sign Up For FreeTo access detailed company insights
Byondis is a biotechnology company focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. They leverage their proprietary platforms and integrated R&D and manufacturing capabilities to create novel therapies that enhance selectivity and therapeutic index. Their product pipeline includes promising candidates targeting... Read More
